178 related articles for article (PubMed ID: 21766430)
1. How do we know if an exposure is actually teratogenic in humans?
Friedman JM
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):170-4. PubMed ID: 21766430
[TBL] [Abstract][Full Text] [Related]
2. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.
Czeizel AE
Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262
[TBL] [Abstract][Full Text] [Related]
3. Big risks in small groups: The difference between epidemiology and counselling.
Friedman JM
Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
[TBL] [Abstract][Full Text] [Related]
4. [Wilson's principles--a base of modern teratology].
Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R
Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275
[TBL] [Abstract][Full Text] [Related]
5. [Teratogenic and embryotoxic effects of caffeine: facts and hypotheses].
Burdan F
Pol Merkur Lekarski; 2000 Oct; 9(52):726-8. PubMed ID: 11144068
[TBL] [Abstract][Full Text] [Related]
6. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
7. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
[TBL] [Abstract][Full Text] [Related]
8. Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.
Chambers CD
Congenit Anom (Kyoto); 2011 Mar; 51(1):16-20. PubMed ID: 21158951
[TBL] [Abstract][Full Text] [Related]
9. The importance of dysmorphology in the identification of new human teratogens.
Jones KL; Carey JC
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):188-94. PubMed ID: 21766438
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
[TBL] [Abstract][Full Text] [Related]
11. Are azole fungicides a teratogenic risk for human conceptus?
Giavini E; Menegola E
Toxicol Lett; 2010 Oct; 198(2):106-11. PubMed ID: 20633616
[TBL] [Abstract][Full Text] [Related]
12. Selection of controls in case-control studies on maternal medication use and risk of birth defects.
Bakker MK; de Walle HE; Dequito A; van den Berg PB; de Jong-van den Berg LT
Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):652-6. PubMed ID: 17668455
[TBL] [Abstract][Full Text] [Related]
13. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
15. Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity.
Timmermann G; Acs N; Bánhidy F; Czeizel AE
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):815-25. PubMed ID: 19551756
[TBL] [Abstract][Full Text] [Related]
16. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
17. Teratogenic exposures.
Običan S; Scialli AR
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):150-69. PubMed ID: 21766437
[TBL] [Abstract][Full Text] [Related]
18. Search for teratogenic risks with the aid of malformation registries.
Källén B
Teratology; 1987 Feb; 35(1):47-52. PubMed ID: 3563936
[TBL] [Abstract][Full Text] [Related]
19. Paternal exposure and counselling: experience of a Teratology Information Service.
De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
[TBL] [Abstract][Full Text] [Related]
20. ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
Friedman JM
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):670-6. PubMed ID: 22786781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
